Large German vaccine firm abandons plans for SA factory

A vial of the Pfizer BioNTech vaccine for coronavirus treatment. Spain has exceeded 32 million people vaccinated with the full schedule. BioNTech is revising plans to build a manufacturing network of vaccine plants in three countries in Africa, just over a year after breaking ground on the first facility in Rwanda.

In response to questions from Bloomberg, BioNTech said its “goal of helping to democratize access to innovative medicines remains unchanged.” It said work to establish commercial-scale vaccine facilities in Rwanda is under way, but it made no reference to manufacturing in South Africa. It said it’s currently focused on conducting clinical trials on an mRNA-based tuberculosis shot in the country at the foot of the continent.

Each BioNTainer module is composed of six ISO-sized shipping containers, and the Rwanda site will have two modules. Though the modules are self-sufficient, they rely on local infrastructure for logistics, quality control, warehousing and cold and frozen storage, according to a

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Learnerships will get South Africa Working - South Africa TodayDelivering Accessible Learning Environments and Job Opportunities for School Leavers In the lead-up to the Matric class of 2023’s final exams, anxiety looms. While some will pursue tertiary education, the majority face the highly competitive job market and the harsh prospect of unemployment. Rajan Naidoo, Managing Director of EduPower Skills Academy, says that in this […]
Source: SATodayNews - 🏆 44. / 51 Read more »